XML 45 R35.htm IDEA: XBRL DOCUMENT v3.23.3

Investment in Cyclo Therapeutics, Inc. (Tables)

3 Months Ended

Oct. 31, 2023

Investment in Cyclo Therapeutics, Inc. [Abstract]

Schedule of Fair Value Method Investment

Summarized Fair Value Method Investment Details

		Ownership %				Aggregate Fair Value (in thousands)
		October 31, 2023				October 31, 2023
Cyclo			40	%		$	9,849

X

- References

No definition available.

+ Details

Name:	us-gaap_InvestmentsAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of fair value of asset supporting separate account.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef
-Topic 944
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 15
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479808/944-20-55-15

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Topic 944
-SubTopic 80
-Name Accounting Standards Codification
-Section 55
-Paragraph 17
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480078/944-80-55-17

Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 944
-SubTopic 80
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480109/944-80-50-1

+ Details

Name:	us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration